Ian Shaw

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

John G Williams, M Fasihul Alam, Laith Alrubaiy et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 250 citations · Full text

Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis

Thomas Creed, M. R. Norman, C Probert et al. · Alimentary Pharmacology & Therapeutics · 2003 · 132 citations · Full text

Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK

Rukshana Kapasi, Jackie Glatter, Christopher A Lamb et al. · Frontline Gastroenterology · 2019 · 100 citations · Full text

Identifying small-molecule lead compounds: The screening approach to drug discovery

Paul Bevan, Hamish Ryder, Ian Shaw · Trends in biotechnology · 1995 · 83 citations

Medicinal Chemistry, Drug Target, Hit Identification +11

Is <i><scp>H</scp>elicobacter pylori</i> antibiotic resistance surveillance needed and how can it be delivered?

Cliodna McNulty, Gemma Lasseter, Ian Shaw et al. · Alimentary Pharmacology & Therapeutics · 2012 · 77 citations · Full text